Efficacy of adjunctive low-dose cariprazine in major depressive disorder: a randomized, double-blind, placebo-controlled trial.

Int Clin Psychopharmacol · 2018 · PMC6166709 · PMID 30045066

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

CGI-I response rates did not reach statistical significance, but were nonsignificantly greater with cariprazine 1.0–2.0 mg/day (Table 2 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.